Skip to main content

Autoradiographic Distributions of Neurotransmitter Receptors in the Brain of Patients with Parkinson’s Disease and MPTP-induced Monkey Parkinsonism

  • Conference paper
Neurology
  • 166 Accesses

Abstract

Parkinson’s disease is a slowly progressive degenerative disorder which is pathologically characterized by neuronal loss of the substantia nigra. Biochemically, deficiency of dopamine in the striatum resulting from degeneration and loss of dopaminergic neurons in the substantia nigra has been confirmed. In addition, from experiments using autopsied human materials [1–6], abnormalities have been reported in the dopaminergic as well as in the following systems: acetylcholine, GABA, serotonin, noradrenaline, and peptide-containing neurons. Recently, it was discovered that 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a by-product in the synthesis of MPPP (1-methyl-4-phenyl-4-propionoxy-piperidine), is selectively toxic to the zona compacta of the substantia nigra [7]. In this paper, we report on observed distributions of neurotransmitter receptors in brains of patients with Parkinson’s disease and those of primate models with MPTP-induced parkinsonism.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bokobza B, Ruberg M, Scatton B, Javoy-Agid F, Agid Y (1984) [3H] spiperone binding, dopamine and HVA concentrations in Parkinson’s disease and supranuclear palsy. Eur J Pharmacol 99: 167–175

    Article  PubMed  CAS  Google Scholar 

  2. Llorens-Cortes C, Javoy-Agid F, Agid Y, Taquet H, Schwartz JC (1984) Enkephalinergic markers in substantia nigra and caudate nucleus from parkinsonian subjects. J Neurochem 43: 874–877

    Article  PubMed  CAS  Google Scholar 

  3. Lloyd KD, Shemen L, Hornykiewicz O (1977) Distribution of high affinity sodium-independent [3H]gamma-aminobutyric acid ([3H]GABA) binding in the human brain: alterations in Parkinson’s disease. Brain Res 127: 269–278

    Article  CAS  Google Scholar 

  4. Mayeux R, Stern Y, Cote L, Williams JBW (1984) Altered serotonin metabolism in depressed patients with Parkinson’s disease. Neurology 34: 642–646

    PubMed  CAS  Google Scholar 

  5. Reisine TD, Fields JZ, Yamamura HI, Bird ED, Spokes E, Schreiner PS, Enna SJ (1977) Neurotransmitter receptor alterations in Parkinson’s disease. Life Sci 21: 335–344

    Article  PubMed  CAS  Google Scholar 

  6. Tenovuo O, Rinne UK, Viljanen MK (1984) Substance P immunoreactivity in the postmortem parkinsonian brain. Brain Res 303: 113–116

    Article  PubMed  CAS  Google Scholar 

  7. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars com- pacta of the substantia nigra by N-methyl-4-phenyl-l,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80: 4546–4550

    Article  PubMed  CAS  Google Scholar 

  8. Youg III W, Kuhar MJ (1979) A new method for receptor autoradiography: [3H] opioid receptors in rat brain. Brain Res 179: 255–279

    Article  Google Scholar 

  9. Fuxe K, Agnati LF, Kohler C, Andersson K, Eneroth P, Calza L, Ogren SO (1983) Heterogeneity of brain dopamine systems: possible discrimination of different types of dopamine systems and receptors by ergot drugs. In: Calne DB (ed) Lisuride and other dopamine agonists. Raven, New York, pp 11–31

    Google Scholar 

  10. Spano PF, Govoni S, Uzumaki H, Bosio A, Memo M, Lucchi L, Carruba M, Trabucchi M (1983) Stimulation of D2 dopamine receptors by dopaminergic ergot alkaloids: studies on the mechanism of action. In: Agonoli A (ed) Aging brain and ergot alkaloids. Raven, New York, pp 165–177

    Google Scholar 

  11. Rosenfeld MR, Makman MH (1981) The interaction of lisuride, an ergot derivative, with serotonergic and dopaminergic receptors in rabbit brain. J Pharmacol and Exp Ther 216: 526–531

    CAS  Google Scholar 

  12. Cote TE, Eskay RL, Frey EA, Crewe CW, Munemura M, Tsuruta K, Brouwn EM, Kebabian JW (1983) Actions of lisuride on adrenoceptors and dopamine receptors. In: Calne DB (ed) Lisuride and other dopamine agonists. Raven, New York, pp 45–53

    Google Scholar 

  13. Hong JS, Yang HYT, Racagni G, Costa E (1977) Projections of substance P containing neurons from neostriatum to substantia nigra. Brain Res 122: 541–544

    Article  PubMed  CAS  Google Scholar 

  14. Kanazawa I, Emson PC, Cuello AC (1977) Evidence for the existence of substance P containing fibers in striato-nigral and pallido-nigral pathways in rat brain. Brain Res 119: 447–453

    Article  PubMed  CAS  Google Scholar 

  15. Morz EA, Brownstein MJ, Leeman SE (1977) Evidence for substance P in the striato-nigral tract. Brain Res 125: 305–311

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Kito, S., Miyoshi, R., Mizuno, K., Nitta, K., Matsubayashi, H., Yamamura, Y. (1986). Autoradiographic Distributions of Neurotransmitter Receptors in the Brain of Patients with Parkinson’s Disease and MPTP-induced Monkey Parkinsonism. In: Poeck, K., Freund, HJ., Gänshirt, H. (eds) Neurology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70007-1_67

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70007-1_67

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70009-5

  • Online ISBN: 978-3-642-70007-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics